|
1
|
Napier KJ, Scheerer M and Misra S:
Esophageal cancer: A Review of epidemiology, pathogenesis, staging
workup and treatment modalities. World J Gastrointest Oncol.
6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lambert R and Hainaut P: The
multidisciplinary management of gastrointestinal cancer.
Epidemiology of oesophagogastric cancer. Best Pract Res Clin
Gastroenterol. 21:921–945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alsop BR and Sharma P: Esophageal Cancer.
Gastroenterol Clin North Am. 45:399–412. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cairns RA, Harris IS and Mak TW:
Regulation of cancer cell metabolism. Nat Rev Cancer. 11:85–95.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pinheiro C, Longatto-Filho A,
Azevedo-Silva J, Casal M, Schmitt FC and Baltazar F: Role of
monocarboxylate transporters in human cancers: State of the art. J
Bioenerg Biomembr. 44:127–139. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brahimi-Horn MC, Bellot G and Pouyssegur
J: Hypoxia and energetic tumour metabolism. Curr Opin Genet Dev.
21:67–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eilertsen M, Andersen S, Al-Saad S,
Kiselev Y, Donnem T, Stenvold H, Pettersen I, Al-Shibli K,
Richardsen E, Busund LT, et al: Monocarboxylate transporters 1–4 in
NSCLC: MCT1 is an independent prognostic marker for survival. PLoS
One. 9:e1050382014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Afonso J, Santos LL, Miranda-Goncalves V,
Morais A, Amaro T, Longatto-Filho A and Baltazar F: CD147 and
MCT1-potential partners in bladder cancer aggressiveness and
cisplatin resistance. Mol Carcinog. 54:1451–1466. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao Z, Wu MS, Zou C, Tang Q, Lu J, Liu D,
Wu Y, Yin J, Xie X, Shen J, et al: Downregulation of MCT1 inhibits
tumor growth, metastasis and enhances chemotherapeutic efficacy in
osteosarcoma through regulation of the NF-kappaB pathway. Cancer
Lett. 342:150–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johnson JM, Cotzia P, Fratamico R,
Mikkilineni L, Chen J, Colombo D, Mollaee M, Whitaker-Menezes D,
Domingo-Vidal M, Lin Z, et al: MCT1 in invasive ductal carcinoma:
Monocarboxylate metabolism and aggressive breast cancer. Front Cell
Dev Biol. 5:272017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kawahara K, Maekawa T, Okabayashi K,
Shiraishi T, Yoshinaga Y, Yoneda S, Hideshima T and Shirakusa T:
The number of lymph node metastases influences survival in
esophageal cancer. J Surg Oncol. 67:160–163. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng JF, Huang Y and Zhao Q: Tumor length
in elderly patients with esophageal squamous cell carcinoma: Is it
a prognostic factor? Ups J Med Sci. 118:145–152. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jeon JY, Lee M, Whang SH, Kim JW, Cho A
and Yun M: Regulation of acetate utilization by monocarboxylate
transporter 1 (MCT1) in hepatocellular carcinoma (HCC). Oncol Res.
26:71–81. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Silva LS, Poschet G, Nonnenmacher Y,
Becker HM, Sapcariu S, Gaupel AC, Schlotter M, Wu Y, Kneisel N,
Seiffert M, et al: Branched-chain ketoacids secreted by
glioblastoma cells via MCT1 modulate macrophage phenotype. EMBO
Rep. 18:2172–2185. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Choi JW, Kim Y, Lee JH and Kim YS:
Prognostic significance of lactate/proton symporters MCT1, MCT4,
and their chaperone CD147 expressions in urothelial carcinoma of
the bladder. Urology. 84:245 e249–215. 2014. View Article : Google Scholar
|
|
20
|
Ambrosetti D, Dufies M, Dadone B, Durand
M, Borchiellini D, Amiel J, Pouyssegur J, Rioux-Leclercq N, Pages
G, Burel- Vandenbos F and Mazure NM: The two glycolytic markers
GLUT1 and MCT1 correlate with tumor grade and survival in
clear-cell renal cell carcinoma. PLoS One. 13:e01934772018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang J, Quinones QJ, Holman TL, Morowitz
MJ, Wang Q, Zhao H, Sivo F, Maris JM and Wahl ML: The
H+-linked monocarboxylate transporter
(MCT1/SLC16A1): A potential therapeutic target for high-risk
neuroblastoma. Mol Pharmacol. 70:2108–2115. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim Y, Choi JW, Lee JH and Kim YS:
Expression of lactate/H+ symporters MCT1 and MCT4 and
their chaperone CD147 predicts tumor progression in clear cell
renal cell carcinoma: Immunohistochemical and The Cancer Genome
Atlas data analyses. Hum Pathol. 46:104–112. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takada T, Takata K and Ashihara E:
Inhibition of monocarboxylate transporter 1 suppresses the
proliferation of glioblastoma stem cells. J Physiol Sci.
66:387–396. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Miranda-Goncalves V, Honavar M, Pinheiro
C, Martinho O, Pires MM, Pinheiro C, Cordeiro M, Bebiano G, Costa
P, Palmeirim I, et al: Monocarboxylate transporters (MCTs) in
gliomas: Expression and exploitation as therapeutic targets. Neuro
Oncol. 15:172–188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Payen VL, Hsu MY, Radecke KS, Wyart E,
Vazeille T, Bouzin C, Porporato PE and Sonveaux P: Monocarboxylate
transporter MCT1 promotes tumor metastasis independently of its
activity as a lactate transporter. Cancer Res. 77:5591–5601. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sonveaux P, Copetti T, De Saedeleer CJ,
Végran F, Verrax J, Kennedy KM, Moon EJ, Dhup S, Danhier P, Frérart
F, et al: Targeting the lactate transporter MCT1 in endothelial
cells inhibits lactate-induced HIF-1 activation and tumor
angiogenesis. PLoS One. 7:e334182012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koppenol WH, Bounds PL and Dang CV: Otto
Warburg's contributions to current concepts of cancer metabolism.
Nat Rev Cancer. 11:325–337. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shi Q, Le X, Wang B, Abbruzzese JL, Xiong
Q, He Y and Xie K: Regulation of vascular endothelial growth factor
expression by acidosis in human cancer cells. Oncogene.
20:3751–3756. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rozhin J, Sameni M, Ziegler G and Sloane
BF: Pericellular pH affects distribution and secretion of cathepsin
B in malignant cells. Cancer Res. 54:6517–6525. 1994.PubMed/NCBI
|
|
30
|
Swietach P, Vaughan-Jones RD and Harris
AL: Regulation of tumor pH and the role of carbonic anhydrase 9.
Cancer Metastasis Rev. 26:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xu L and Fidler IJ: Acidic pH-induced
elevation in interleukin 8 expression by human ovarian carcinoma
cells. Cancer Res. 60:46102000.PubMed/NCBI
|
|
32
|
Yu P, Liu Q, Liu K, Yagasaki K, Wu E and
Zhang G: Matrine suppresses breast cancer cell proliferation and
invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology.
59:219–229. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gray AL, Coleman DT, Shi R and Cardelli
JA: Monocarboxylate transporter 1 contributes to growth
factor-induced tumor cell migration independent of transporter
activity. Oncotarget. 7:32695–32706. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yan C, Yang F, Zhou C, Chen X, Han X, Liu
X, Ma H and Zheng W: MCT1 promotes the cisplatin-resistance by
antagonizing fas in epithelial ovarian cancer. Int J Clin Exp
Pathol. 8:2710–2718. 2015.PubMed/NCBI
|
|
36
|
Bola BM, Chadwick AL, Michopoulos F,
Blount KG, Telfer BA, Williams KJ, Smith PD, Critchlow SE and
Stratford IJ: Inhibition of monocarboxylate transporter-1 (MCT1) by
AZD3965 enhances radiosensitivity by reducing lactate transport.
Mol Cancer Ther. 13:2805–2816. 2014. View Article : Google Scholar : PubMed/NCBI
|
